Can a network meta-analysis be used to determine the effect of antihypertensive drugs on the risk of incident diabetes?
Finlay A McAlister
Correspondence Division of General Internal Medicine, 2E3.24 Walter Mackenzie Centre, University of Alberta, 8440 112th Street, Edmonton, AB T6G 2B7, Canada
Email finlay.mcalister@ualberta.ca
This article has no abstract so we have provided the first paragraph of the full text.
The benefits of antihypertensive agents for cardiovascular disease prevention are largely related to the degree of blood pressure-lowering achieved.1 Some clinicians have, therefore, expressed interest in whether specific drug classes cause or prevent diabetes (a common comorbid condition with hypertension) as a rationale for choosing between drug classes.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
